Monday, 12 November 2018

Nifty, Sensex Under Pressure – Monday closing report-The Total Investment & Insurance Solutions

Contact Your Financial Adviser Money Making MC

12 November 2018


The major indices of the Indian stock markets suffered a correction on Monday and closed with losses over Friday’s close. On the NSE, there were 640 advances, 1,105 declines and 328 unchanged. The trends of the major indices in the course of Monday’s trading are given in the table below:


The key Indian equity indices pared their initial gains to trade lower during on Monday, as investors turned cautious ahead of the release of key macro-economic indicators. The government would release the Consumer Price Index (CPI) for October and the industrial production data for September later in the day. The CPI data for September stood at 3.77%, up from 3.69 in August. Also, rebound in global crude oil prices and depreciation in the rupee weighed on the indices during the day. Price of Brent crude oil rose around $1.42 per barrel to $71.60 on Monday. Finally, the major indices suffered a correction of the order of 1% over Friday’s close.

Macro-economic indicators such as inflation, factory output as well as global crude oil prices will dictate the stock market trend this week, analysts said. A string of assembly elections, starting November 12, will also drive investor sentiments after range-bound movement the previous week. The government will release Consumer Price Index (CPI) and Wholesale Price Index (WPI) data for October this week. Retail inflation for September was at 3.77%, up from 3.69 in August. The wholesale inflation rose to 5.13% in September, from 4.53% in August.  Assembly elections have kickstarted with the first phase of elections in Chhattisgarh on Monday, November 12. Madhya Pradesh, Rajasthan, Chhattisgarh, Telangana and Mizoram go to polls this month and the next to reconstitute their respective assemblies. Also, crude oil prices, which have eased recently, would guide the equity market next week, analysts said.

Bank of India reported Q2FY19 results with net interest income (NII) at Rs2,926.79 crore (Rs2,908.24 crore), up 0.60% year-on-year. Losses were at Rs1,156.25 crore (profit of Rs179.07 crore). NPA (non-performing assets) provisions were at Rs2,827.62 crore (Rs1,866.82 crore). Gross Net Performing Assets (GNPA) were at 16.36% (12.62%). Net non-performing assets (NNPA) were at 7.64% (6.47%). The bank’s shares closed at Rs86.90, down 5.23% on the NSE.

Britannia Industries reported Q2 FY19 (Consolidated) results which included revenues at Rs2,869.59 crore (Rs2,545.29 crore), up 12.7% year-on-year. Net profit was at Rs302.97 crore (Rs261.05 crore), up 16.1% year-on-year. Earnings per share were at Rs25.22 (Rs21.74). The company’s shares closed at Rs5,765.00, up 0.32% on the NSE.

Ratnamani Metals & Tubes has received a new domestic order valued at approx. Rs165.00 crore for supply of CS Pipes for Oil & Gas Sector. The company’s shares closed at Rs875.50, up 0.14% on the NSE.

Zydus Cadila has received the final approval from the US FDA (Food and Drug Administration) to market Nystatin and Triamcinolone Acetonide Ointment USP. It is used to treat fungal skin infections. The company’s shares closed at Rs356.20, down 1.12% on the NSE.

Cipla has received final approval for its ANDA for Valganciclovir Tablets 450mg from US FDA. The drug is AB-rated generic version of Roche’s Valcyte® used in the treatment of CMV retinitis in patients with AIDS. Cipla shares closed at Rs530.80, up 0.73% on the NSE.

Lupin received Establishment Inspection report (EIR) for its Nagpur facility in Maharashtra post the completion of a Pre-Approval Inspection for its Phenytoin Sodium Extended Release 100 mg capsules. The inspection conducted in September 2018 concluded without any observation. The company’s shares closed at Rs859.25, up 0.51% on the NSE.

The top gainers and top losers of the major indices are given in the table below:


The closing values of the major Asian indices are given in the table below:
financial markets (The Total Investment & Insurance Solutions


No comments:

Post a Comment